Document is current
Any future updates will be listed below
-
Authors
Giannakou, Andreas
Kantor, Olga
Park, Ko Un
Waks, Adrienne G.
Punglia, Rinaa S.
Dominici, Laura S.
Nakhlis, Faina
Mittendorf, Elizabeth A.
King, Tari A.
- License Information
-
More Information
Article History
First Online: 9 November 2024
Disclosures
: E.A.M. reports compensated service on scientific advisory boards for AstraZeneca, BioNTech, Merck, and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speaker’s honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. E.A.M. also reports research funding from Susan Komen for the Cure for which she serves as a scientific advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. T.A.K. reports speaker honoraria for Exact Sciences and compensated service on the FES Steering Committee, GE Healthcare, and compensated service as faculty for PrecisCa cancer information service. A.G.W. reports research funding to institution from Genentech, Gilead, Macrogenics, and Merck; consulting fees from AstraZeneca and AMBRX; and speaker honoraria from AstraZeneca. The remaining authors declare no conflicts of interest.
